By Andrew Chung NEW YORK (Reuters) – A U.S. judge on Monday found a pattern of misconduct by Merck & Co including lying under oath and other unethical practices, freeing Gilead Sciences Inc from paying any damages for infringing Merck’s patents with its lucrative treatments…
Read More
Latest in Lainie Keller Archives - Access International Patent